Richard Band

Richard Band

Richard Band is the author of Contrary Investing, in addition to numerous investment monographs. He has appeared on financial radio and TV and has been quoted in The Wall Street Journal, Business Week, Forbes and other leading publications. Richard graduated from Yale University, magna cum laude, and has been a respected investment commentator since 1982.

Recent Articles

Scoop Up Teva Pharmaceutical Industries Ltd (ADR) on Every Dip

Drug company Teva Pharmaceutical is down but not out. The turnaround plan has TEVA stock in an excellent position.

Healthcare Trust of America Inc Stock Is Solid Long-Term Choice

HTA stock is a worthy long-term healthcare choice. Here's what investors need to know about Healthcare Trust of America.

Is AT&T Inc. Stock Still Worth Its 5%-Plus Dividend?

Although AT&T stock has had a rough road lately, you shouldn't count it out. T stock can still weather storms that would sink others.

The Vanguard Health Care ETF Is a Strong Buy After Its Powerful Rally

Now that the tax bill is done, healthcare will be back in 2018 and VHT will shine. Here's what investors need to know about the Vanguard Health Care ETF.

Microsoft Corporation Has Plenty of Potential in 2018

Microsoft still has a lot going for it, which is great news for investors looking for a blue-chip tech stock with plenty of growth but little premium.